DOI: 10.1055/s-00023610

Drug Research

References

Mosenzon O, Blicher TM, Rosenlund S. et al.
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): A placebo-controlled, randomised, phase 3a trial.

Lancet Diabetes Endocrinol 2019;
7: 515-527

Download Bibliographical Data

Access:
Access:
Access: